CROSSROADS STRATEGIES, LLC for ALKERMES, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advance the use of FDA-approved medicines to treat addiction in criminal justice and public health settings. Confronting the opioid and mental illness epidemic including funding issues. Implementation of Comprehensive Addiction and Recovery Act of 2016 (P.L.114-198). Implementation of 21st Century Cures Act (P.L.114-255). Implementation of SUPPORT for Patients and Communities Act (P.L.115-271). H.J.Res.31, Consolidated Appropriations Act, 2019 (P.L.116-6). FY 2020 Commerce, Justice, Science, and Related Agencies Appropriations. FY 2020 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| STEWART HALL | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.